These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 21182798)
1. Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a. Ohyashiki JH; Umezu T; Kobayashi C; Hamamura RS; Tanaka M; Kuroda M; Ohyashiki K BMC Res Notes; 2010 Dec; 3():347. PubMed ID: 21182798 [TBL] [Abstract][Full Text] [Related]
2. Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia. Gado MM; Mousa NO; Badawy MA; El Taweel MA; Osman A Asian Pac J Cancer Prev; 2019 Dec; 20(12):3625-3633. PubMed ID: 31870103 [TBL] [Abstract][Full Text] [Related]
3. Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia. Elhamamsy AR; El Sharkawy MS; Zanaty AF; Mahrous MA; Mohamed AE; Abushaaban EA Int J Mol Cell Med; 2017; 6(2):77-86. PubMed ID: 28890884 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia. Papageorgiou SG; Diamantopoulos MA; Kontos CK; Bouchla A; Vasilatou D; Bazani E; Scorilas A; Pappa V Leuk Lymphoma; 2019 Mar; 60(3):658-667. PubMed ID: 29911923 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. Tanaka M; Oikawa K; Takanashi M; Kudo M; Ohyashiki J; Ohyashiki K; Kuroda M PLoS One; 2009; 4(5):e5532. PubMed ID: 19440243 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-92a as a marker of treatment response and survival in adult acute myeloid leukemia patients. Rashed RA; Hassan NM; Hussein MM Leuk Lymphoma; 2020 Oct; 61(10):2475-2481. PubMed ID: 32536234 [TBL] [Abstract][Full Text] [Related]
7. Blockage of miR-92a-3p with locked nucleic acid induces apoptosis and prevents cell proliferation in human acute megakaryoblastic leukemia. Sharifi M; Salehi R Cancer Gene Ther; 2016 Jan; 23(1):29-35. PubMed ID: 26658357 [TBL] [Abstract][Full Text] [Related]
8. Plasma exosome-encapsulated microRNA-21 and microRNA-92a are promising biomarkers for the prediction of peritoneal recurrence in patients with gastric cancer. Soeda N; Iinuma H; Suzuki Y; Tsukahara D; Midorikawa H; Igarashi Y; Kumata Y; Horikawa M; Kiyokawa T; Fukagawa T; Fukushima R Oncol Lett; 2019 Nov; 18(5):4467-4480. PubMed ID: 31611956 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of microRNA miR-92a induces apoptosis and necrosis in human acute promyelocytic leukemia. Sharifi M; Salehi R; Gheisari Y; Kazemi M Adv Biomed Res; 2014; 3():61. PubMed ID: 24627869 [TBL] [Abstract][Full Text] [Related]
10. Downregulated miR-17, miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in T cell acute lymphoblastic leukemia. He Z; Liao Z; Chen S; Li B; Yu Z; Luo G; Yang L; Zeng C; Li Y Asia Pac J Clin Oncol; 2018 Oct; 14(5):e259-e265. PubMed ID: 29749698 [TBL] [Abstract][Full Text] [Related]
11. Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders. Yoshizawa S; Ohyashiki JH; Ohyashiki M; Umezu T; Suzuki K; Inagaki A; Iida S; Ohyashiki K Blood Cancer J; 2012 Jan; 2(1):e53. PubMed ID: 22829237 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1. Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-92a serves as a risk factor in sepsis-induced ARDS and regulates apoptosis and cell migration in lipopolysaccharide-induced HPMEC and A549 cell injury. Xu F; Yuan J; Tian S; Chen Y; Zhou F Life Sci; 2020 Sep; 256():117957. PubMed ID: 32534035 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
15. Altered expression of miR-92a correlates with Th17 cell frequency in patients with primary biliary cirrhosis. Liang DY; Hou YQ; Luo LJ; Ao L Int J Mol Med; 2016 Jul; 38(1):131-8. PubMed ID: 27246196 [TBL] [Abstract][Full Text] [Related]
16. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Wu CW; Ng SS; Dong YJ; Ng SC; Leung WW; Lee CW; Wong YN; Chan FK; Yu J; Sung JJ Gut; 2012 May; 61(5):739-45. PubMed ID: 21930727 [TBL] [Abstract][Full Text] [Related]
17. Plasma miR-92a-2 as a biomarker for small cell lung cancer. Yu Y; Zuo J; Tan Q; Zar Thin K; Li P; Zhu M; Yu M; Fu Z; Liang C; Tu J Cancer Biomark; 2017; 18(3):319-327. PubMed ID: 28106539 [TBL] [Abstract][Full Text] [Related]
18. Plasma Hsa-miR-92a-3p in correlation with lipocalin-2 is associated with sepsis-induced coagulopathy. Wang Y; Wang H; Zhang C; Zhang C; Yang H; Gao R; Tong Z BMC Infect Dis; 2020 Feb; 20(1):155. PubMed ID: 32075600 [TBL] [Abstract][Full Text] [Related]
19. Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma. Ohyashiki K; Umezu T; Yoshizawa S; Ito Y; Ohyashiki M; Kawashima H; Tanaka M; Kuroda M; Ohyashiki JH PLoS One; 2011 Feb; 6(2):e16408. PubMed ID: 21383985 [TBL] [Abstract][Full Text] [Related]
20. Atherosclerotic Conditions Promote the Packaging of Functional MicroRNA-92a-3p Into Endothelial Microvesicles. Liu Y; Li Q; Hosen MR; Zietzer A; Flender A; Levermann P; Schmitz T; Frühwald D; Goody P; Nickenig G; Werner N; Jansen F Circ Res; 2019 Feb; 124(4):575-587. PubMed ID: 30582459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]